• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板蛋白 S 通过控制血栓中的凝血来限制静脉血栓形成倾向,但不限制动脉血栓形成倾向。

Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus.

机构信息

Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, and.

Department for BioMedical Research, University of Bern, Bern, Switzerland.

出版信息

Blood. 2020 May 28;135(22):1969-1982. doi: 10.1182/blood.2019003630.

DOI:10.1182/blood.2019003630
PMID:32276277
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7256357/
Abstract

Anticoagulant protein S (PS) in platelets (PSplt) resembles plasma PS and is released on platelet activation, but its role in thrombosis has not been elucidated. Here we report that inactivation of PSplt expression using the Platelet factor 4 (Pf4)-Cre transgene (Pros1lox/loxPf4-Cre+) in mice promotes thrombus propensity in the vena cava, where shear rates are low, but not in the carotid artery, where shear rates are high. At a low shear rate, PSplt functions as a cofactor for both activated protein C and tissue factor pathway inhibitor, thereby limiting factor X activation and thrombin generation within the growing thrombus and ensuring that highly activated platelets and fibrin remain localized at the injury site. In the presence of high thrombin concentrations, clots from Pros1lox/loxPf4-Cre- mice contract, but not clots from Pros1lox/loxPf4-Cre+ mice, because of highly dense fibrin networks. Thus, PSplt controls platelet activation as well as coagulation in thrombi in large veins, but not in large arteries.

摘要

血小板中的抗凝蛋白 S(PS)类似于血浆 PS,在血小板激活时释放,但它在血栓形成中的作用尚未阐明。在这里,我们报告使用血小板因子 4(Pf4)-Cre 转基因(Pros1lox/loxPf4-Cre+)在小鼠中失活 PSplt 表达,可促进低剪切速率下腔静脉中的血栓倾向,但不促进高剪切速率下颈动脉中的血栓倾向。在低剪切速率下,PSplt 作为活化蛋白 C 和组织因子途径抑制剂的辅助因子,从而限制了生长中的血栓内的因子 X 激活和凝血酶生成,并确保高度活化的血小板和纤维蛋白仍定位于损伤部位。在存在高浓度凝血酶的情况下,由于高度密集的纤维蛋白网络,Pros1lox/loxPf4-Cre- 小鼠的血栓收缩,但 Pros1lox/loxPf4-Cre+ 小鼠的血栓不收缩。因此,PSplt 控制着大静脉中血栓形成中的血小板激活和凝血,但不控制大动脉中的血小板激活和凝血。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f094/7256357/c28b5bc6735a/bloodBLD2019003630absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f094/7256357/c28b5bc6735a/bloodBLD2019003630absf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f094/7256357/c28b5bc6735a/bloodBLD2019003630absf1.jpg

相似文献

1
Platelet protein S limits venous but not arterial thrombosis propensity by controlling coagulation in the thrombus.血小板蛋白 S 通过控制血栓中的凝血来限制静脉血栓形成倾向,但不限制动脉血栓形成倾向。
Blood. 2020 May 28;135(22):1969-1982. doi: 10.1182/blood.2019003630.
2
Platelet-Derived TGF-β1 Promotes Deep Vein Thrombosis.血小板衍生的 TGF-β1 促进深静脉血栓形成。
Thromb Haemost. 2024 Jul;124(7):641-648. doi: 10.1055/a-2235-7485. Epub 2023 Dec 27.
3
Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions.VIII 因子在低切变条件下通过生成凝血酶促进血小板-纤维蛋白血栓形成。
Thromb Res. 2009 Nov;124(5):601-7. doi: 10.1016/j.thromres.2009.06.035. Epub 2009 Aug 6.
4
Epidermal growth factor-like repeats of SCUBE1 derived from platelets are critical for thrombus formation.血小板衍生的 SCUBE1 表皮生长因子样重复序列对于血栓形成至关重要。
Cardiovasc Res. 2020 Jan 1;116(1):193-201. doi: 10.1093/cvr/cvz036.
5
Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.血小板促凝血活性在体内小动脉和小静脉中组织因子和胶原依赖性血栓形成中的关键作用:对凝血酶抑制的差异敏感性。
Microcirculation. 2008 May;15(4):269-82. doi: 10.1080/10739680701653517.
6
Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.鼠造血细胞组织因子途径抑制剂可限制血栓生长。
Arterioscler Thromb Vasc Biol. 2011 Apr;31(4):821-6. doi: 10.1161/ATVBAHA.110.220293. Epub 2011 Jan 13.
7
Platelet-Derived Factor V Is a Critical Mediator of Arterial Thrombosis.血小板衍生因子 V 是动脉血栓形成的关键介质。
J Am Heart Assoc. 2017 Jul 3;6(7):e006345. doi: 10.1161/JAHA.117.006345.
8
Antithrombotic properties of water-soluble carbon monoxide-releasing molecules.水溶性一氧化碳释放分子的抗血栓特性。
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2149-57. doi: 10.1161/ATVBAHA.112.253989. Epub 2012 Jul 5.
9
Rate-limiting roles of the tenase complex of factors VIII and IX in platelet procoagulant activity and formation of platelet-fibrin thrombi under flow.凝血因子VIII和IX的凝血酶原酶复合物在血小板促凝活性及流动状态下血小板-纤维蛋白血栓形成中的限速作用。
Haematologica. 2015 Jun;100(6):748-56. doi: 10.3324/haematol.2014.116863. Epub 2015 Mar 13.
10
Coagulation Factor XI Promotes Distal Platelet Activation and Single Platelet Consumption in the Bloodstream Under Shear Flow.凝血因子XI促进剪切流作用下血流中远端血小板的活化及单个血小板的消耗。
Arterioscler Thromb Vasc Biol. 2016 Mar;36(3):510-7. doi: 10.1161/ATVBAHA.115.307034. Epub 2016 Jan 14.

引用本文的文献

1
Salvianolic acid A inhibits the activation and aggregation of platelets in patients with acute coronary syndrome.丹酚酸A抑制急性冠脉综合征患者血小板的活化和聚集。
Medicine (Baltimore). 2025 Jul 18;104(29):e43305. doi: 10.1097/MD.0000000000043305.
2
Unfolded von Willebrand factor binds protein S and reduces anticoagulant activity.未折叠的血管性血友病因子结合蛋白S并降低抗凝活性。
Blood Vessel Thromb Hemost. 2025 Feb;2(1). doi: 10.1016/j.bvth.2024.100030. Epub 2024 Sep 25.
3
Targeted codelivery of nitric oxide and hydrogen sulfide for enhanced antithrombosis efficacy.

本文引用的文献

1
Interrelationships between structure and function during the hemostatic response to injury.止血反应过程中结构与功能的相互关系。
Proc Natl Acad Sci U S A. 2019 Feb 5;116(6):2243-2252. doi: 10.1073/pnas.1813642116. Epub 2019 Jan 23.
2
A fibrin biofilm covers blood clots and protects from microbial invasion.纤维蛋白生物膜覆盖在血栓上,防止微生物入侵。
J Clin Invest. 2018 Aug 1;128(8):3356-3368. doi: 10.1172/JCI98734. Epub 2018 Jun 25.
3
Targeting anticoagulant protein S to improve hemostasis in hemophilia.靶向抗凝蛋白 S 以改善血友病的止血功能。
一氧化氮和硫化氢的靶向共递送以增强抗血栓形成功效。
Bioact Mater. 2025 Feb 13;48:29-42. doi: 10.1016/j.bioactmat.2025.02.012. eCollection 2025 Jun.
4
Composition of thrombi in zebrafish: similarities and distinctions with mammals.斑马鱼血栓的组成:与哺乳动物的相似性和区别。
J Thromb Haemost. 2024 Apr;22(4):1056-1068. doi: 10.1016/j.jtha.2023.12.025. Epub 2023 Dec 30.
5
Therapeutic targeting of the functionally elusive TAM receptor family.靶向功能隐匿的 TAM 受体家族的治疗方法。
Nat Rev Drug Discov. 2024 Mar;23(3):201-217. doi: 10.1038/s41573-023-00846-8. Epub 2023 Dec 13.
6
Activated protein C, protein S, and tissue factor pathway inhibitor cooperate to inhibit thrombin activation.活化蛋白 C、蛋白 S 和组织因子途径抑制物协同抑制凝血酶的激活。
Thromb Res. 2023 Oct;230:84-93. doi: 10.1016/j.thromres.2023.08.012. Epub 2023 Aug 23.
7
Systemic Review of Clot Retraction Modulators.血栓收缩调节剂的系统评价。
Int J Mol Sci. 2023 Jun 25;24(13):10602. doi: 10.3390/ijms241310602.
8
Platelet tissue factor pathway inhibitor-α dampens cardiac thrombosis and associated fibrosis in mice.血小板组织因子途径抑制剂-α可抑制小鼠心脏血栓形成和相关纤维化。
J Thromb Haemost. 2023 Mar;21(3):639-651. doi: 10.1016/j.jtha.2022.11.034. Epub 2022 Dec 22.
9
Dysregulation of Protein S in COVID-19.COVID-19 中蛋白 S 的失调。
Best Pract Res Clin Haematol. 2022 Sep;35(3):101376. doi: 10.1016/j.beha.2022.101376. Epub 2022 Aug 23.
10
Protein C or Protein S deficiency associates with paradoxically impaired platelet-dependent thrombus and fibrin formation under flow.蛋白C或蛋白S缺乏与血流状态下血小板依赖性血栓形成及纤维蛋白形成的反常受损相关。
Res Pract Thromb Haemost. 2022 Mar 7;6(2):e12678. doi: 10.1002/rth2.12678. eCollection 2022 Feb.
Blood. 2018 Mar 22;131(12):1360-1371. doi: 10.1182/blood-2017-09-800326. Epub 2018 Jan 9.
4
Histological comparison of arterial thrombi in mice and men and the influence of Cl-amidine on thrombus formation.小鼠与人动脉血栓的组织学比较及氯脒对血栓形成的影响。
PLoS One. 2018 Jan 2;13(1):e0190728. doi: 10.1371/journal.pone.0190728. eCollection 2018.
5
Platelet full length TFPI-α in healthy volunteers is not affected by sex or hormonal use.健康志愿者体内的血小板全长组织因子途径抑制物-α不受性别或激素使用情况的影响。
PLoS One. 2017 Feb 3;12(2):e0168273. doi: 10.1371/journal.pone.0168273. eCollection 2017.
6
Hierarchical organization of the hemostatic response to penetrating injuries in the mouse macrovasculature.小鼠大血管穿透伤止血反应的分级组织
J Thromb Haemost. 2017 Mar;15(3):526-537. doi: 10.1111/jth.13600. Epub 2017 Feb 6.
7
Pro- and anticoagulant properties of factor V in pathogenesis of thrombosis and bleeding disorders.凝血因子V的促凝和抗凝特性在血栓形成和出血性疾病发病机制中的作用
Int J Lab Hematol. 2016 May;38 Suppl 1:4-11. doi: 10.1111/ijlh.12508. Epub 2016 May 9.
8
Assessing the Methodology for Calculating Platelet Contribution to Clot Strength (Platelet Component) in Thromboelastometry and Thrombelastography.评估血栓弹力图和血栓弹性描记术中计算血小板对凝血强度贡献(血小板成分)的方法
Anesth Analg. 2015 Oct;121(4):868-878. doi: 10.1213/ANE.0000000000000859.
9
A systems approach to hemostasis: 3. Thrombus consolidation regulates intrathrombus solute transport and local thrombin activity.系统方法研究止血:3.血栓巩固调节血栓内溶质转运和局部凝血酶活性。
Blood. 2014 Sep 11;124(11):1824-31. doi: 10.1182/blood-2014-01-550319. Epub 2014 Jun 20.
10
The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors.有浅静脉血栓形成病史和获得性静脉血栓形成危险因素者的静脉血栓栓塞风险。
Blood. 2013 Dec 19;122(26):4264-9. doi: 10.1182/blood-2013-07-518159. Epub 2013 Nov 1.